Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market
Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market
Report Includes
- Analysis of the global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics
- Analyses of global market trends, with historic revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Estimates of the market’s size and revenue prospects, along with a corresponding market share analysis by symptom type, drug class, disease indication, route of administration, distribution channel and region
- Facts and figures pertaining to market dynamics, technological advances, regulations and the impact of macroeconomic factors
- Insights derived from Porter’s Five Forces model, as well as global supply chain analysis
- Patent analysis, featuring key granted and published patents
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of the leading companies
